Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

shutterstock_291014192

Asia-Pacific NSCLC market to more than double to $6.2bn by 2023

March 21, 2017 Manufacturing and Production, Research and Development, Sales and Marketing BMS, Eli Lilly, MSD, NSCLC, Yervoy, keytruda, opdivo

New research from intelligence provider GBI Research has indicated that the non-small cell lung cancer (NSCLC) market in the Asia-Pacific …
News
lilly_scientists

Lilly’s breast cancer drug meets primary endpoint

March 21, 2017 Manufacturing and Production, Research and Development CDK 4/6 inhibitors, Eli Lilly, abemaciclib

Eli Lilly has announced that its trial of abemaciclib, in combination with fulvestrant, had met its primary endpoint of progression-free …
News

India aims to become “a global innovation hub” for biotechs by 2020

March 21, 2017 Manufacturing and Production, Research and Development India, biotech

The Indian Government has announced its intention to transform the nation into a hub for global biotech activity via its …
News
shutterstock_311949818

Genentech plans second Phase 3 Alzheimer’s trial following endpoint failures

March 20, 2017 Research and Development, Sales and Marketing Alzheimer's, Genentech, Roche

Genentech, Roche’s biotech group, has announced its plans to conduct a second Phase 3 study for crenezumab, its anti-Abeta antibody …
News
pulmocide-logo

UK biotech Pulmocide secures $30m for inhalable lung disease therapies

March 20, 2017 Research and Development, Sales and Marketing pulmocide, pulmonary aspergillosis, respiratory syncytial virus

Pulmocide, a UK biotech run by a former GlaxoSmithKline scientists and based in London, has secured $30.4 million in Series …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

As another week comes and goes, waves were sent through the industry as Trump announced his pick as the new …
News
anirvan_ghosh

Biogen swoops to appoint Ex-Roche Vice President

March 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen

Biogen have appointed Anirvan Ghosh to the position of Senior Vice President of research and Early Development. Ghosh is slated …
Appointment
7808465302_a335c6dd4f_o

The rising threat of antibiotic resistance

March 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance

Last month, researchers from the University of California, Los Angeles (UCLA) revealed findings that showed that utilising antibiotics in combination …
Feature
heartbeat

Decade lifespan difference in Americans and Canadians with cystic fibrosis

March 15, 2017 Research and Development Canada, United States, cystic fibrosis

A new study has emerged looking into life expectancy of those with cystic fibrosis, funded by the US Cystic Fibrosis …
News
opdivo_1_1

NICE recommends against Opdivo for classical Hodgkin lymphoma

March 15, 2017 Research and Development, Sales and Marketing BMS, classical Hodgkin Lymphoma, opdivo

The National Institute of Health and Care Excellence (NICE) has released draft guidance provisionally turning down Bristol-Myers Squibb’s Opdivo (nivolumab) …
News
shutterstock_156022646

FDA-approved preterm birth drug has no benefit and may cause harm, study suggests

March 15, 2017 Research and Development FDA, Makena

A study by the UT Southwestern Medical Center has found that the synthetic progestogen hormone 17-alpha hydroxyprogesterone caproate (17-OHPC), a …
News
merck_and_co

MSD’s Keytruda notches another FDA approval in Hodgkin lymphoma

March 15, 2017 Research and Development, Sales and Marketing Hodgkin lymphoma, MSD, keytruda

MSD, otherwise known as Merck in North America, continues to score indication successes with Keytruda, this time in Hodgkin lymphoma. …
News
sanofi_new_paris_hq

Patients in UK to be given early access to Sanofi’s eczema treatment

March 14, 2017 Research and Development, Sales and Marketing Dupilumab, MHRA, Sanofi

Sanofi’s treatment for atopic dermatitis, otherwise known as eczema, has been given a positive scientific opinion through the MHRA’s Early …
News
cancer_cells

Survivors of Hodgkin lymphoma over twice as likely to suffer second cancer

March 14, 2017 Manufacturing and Production, Research and Development Hodgkin lymphoma, ICR

New research emerging from the Institute for Cancer Research (ICR) has found that those previously treated for Hodgkin lymphoma are …
News
breast_cancer

One in five women with breast cancer could benefit from existing therapy

March 14, 2017 Manufacturing and Production, Research and Development Wellcome Trust Sanger Institute, breast cancer, parp inhibitors

A new study emerging from the Wellcome Trust Sanger Institute has discovered that there are more cases of breast cancer …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025